Severe dopaminergic pathways damage in a case of chronic toluene abuse

Clinical Neurology and Neurosurgery

Volumn 111, Issue 10, 2009, Pages 864-867

  Papageorgiou, Sokratis G ^a   Karantoni, Evgenia ^a   Pandis, Dionysios ^a   Kouzoupis, Anastasios V ^a   Kalfakis, Nikolaos ^a   Limouris, Georgios S ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

DaT scan; Dopamine; Leukoencephalopathy; Neuroleptic malignant syndrome; Toluene

Indexed keywords

CLONAZEPAM; DOPAMINE TRANSPORTER; OLANZAPINE; PIRACETAM; TOLUENE; TOPIRAMATE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN TOXICITY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAY MATTER; HUMAN; LEUKOENCEPHALOPATHY; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANCE ABUSE; TOLUENE ADDICTION; TREATMENT DURATION; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN; CHRONIC DISEASE; DOPAMINE; GAIT DISORDERS, NEUROLOGIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; NEUROTOXICITY SYNDROMES; SOLVENTS; SUBSTANCE-RELATED DISORDERS; TOLUENE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREMOR; YOUNG ADULT;

EID: 70350764012     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.07.007     Document Type: Article

References (22)

1. Aydin K., Sencer S., Demir T., Ogel K., Tunaci A., Minareci O., et al. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol 23 (2002) 1173-1179
2. Borne J., Riascos R., Cuellar H., Vargas D., and Rojas R. Neuroimaging in drug and substance abuse. Part II. Opioids and solvents. Top Magn Reson Imaging 16 (2005) 239-245
3. Kamran S., and Bakshi R. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images. Neuroradiology 40 (1998) 519-521
4. Filley C.M., Halliday W., and Kleinschmidt-DeMasters B.K. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 63 (2004) 1-12
5. EKTEPN. Annual report on drugs and alcohol use in Greece-article in Greek (2007), EPIPSY, Athens 166 pp.
6. Benamer T.S., Patterson J., Grosset D.G., Booij J., de Bruin K., van Royen E., et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15 (2000) 503-510
7. Ottaviani S., Tinazzi M., Pasquin I., Nothdurfter W., Tomelleri G., Fincati E., et al. Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's disease. Neurol Sci 27 (2006) 397-401
8. Paphiti M.I.S.P., Lamprakos L., Panayides C., Rousopoulos K., Stavraka A., and Limouris G.S. Comparison of specific binding index of regional DaTSCAN imaging vs MRI stratial volumetric measurements. European Journal of Nuclear Medicine and Molecular Imaging 34 (2007) 253-411 [Annual Congress of the European Association of Nuclear Medicine Copenhagen Denmark]
9. Uitti R.J., Snow B.J., Shinotoh H., Vingerhoets F.J., Hayward M., Hashimoto S., et al. Parkinsonism induced by solvent abuse. Ann Neurol 35 (1994) 616-619
10. Gautschi O.P., Cadosch D., and Zellweger R. Postural tremor induced by paint sniffing. Neurol India 55 (2007) 393-395
11. Deleu D., and Hanssens Y. Cerebellar dysfunction in chronic toluene abuse: beneficial response to amantadine hydrochloride. J Toxicol Clin Toxicol 38 (2000) 37-41
12. Miyagi Y., Shima F., Ishido K., Yasutake T., and Kamikaseda K. Tremor induced by toluene misuse successfully treated by a Vim thalamotomy. J Neurol Neurosurg Psychiatry 66 (1999) 794-796
13. Rosenberg N.L., Grigsby J., Dreisbach J., Busenbark D., and Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol 40 (2002) 21-34
14. Marshall V., and Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 18 (2003) 1415-1423
15. Booij J., and Kemp P. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging 35 (2008) 424-438
16. Stengard K., Hoglund G., and Ungerstedt U. Extracellular dopamine levels within the striatum increase during inhalation exposure to toluene: a microdialysis study in awake, freely moving rats. Toxicol Lett 71 (1994) 245-255
17. Kondo H., Huang J., Ichihara G., Kamijima M., Saito I., Shibata E., et al. Toluene induces behavioral activation without affecting striatal dopamine metabolism in the rat: behavioral and microdialysis studies. Pharmacol Biochem Behav 51 (1995) 97-101
18. Edling C., Hellman B., Arvidson B., Andersson J., Hartvig P., Lilja A., et al. Do organic solvents induce changes in the dopaminergic system? Positron emission tomography studies of occupationally exposed subjects. Int Arch Occup Environ Health 70 (1997) 180-186
19. Hageman G., van der Hoek J., van Hout M., van der Laan G., Steur E.J., de Bruin W., et al. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. J Neurol 246 (1999) 198-206
20. Kornhuber J., and Weller M. Neuroleptic malignant syndrome. Curr Opin Neurol 7 (1994) 353-357
21. Gerasimov M.R., Schiffer W.K., Marstellar D., Ferrieri R., Alexoff D., and Dewey S.L. Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 65 (2002) 243-251
22. Riegel A.C., and French E.D. Abused inhalants and central reward pathways: electrophysiological and behavioral studies in the rat. Ann NY Acad Sci 965 (2002) 281-291